Hysterectomy and oophorectomy ups risk of cardiovascular disease in women: AHA Dr. Hiral patel16 July 2022 10:45 AM ISTUK: More intensive cardiovascular risk management is indicated in premenopausal women who had a hysterectomy (HA), with or without bilateral...
New AHA guideline which adds sleep to cardiovascular health checklist Isra Zaman1 July 2022 9:15 AM ISTSleep duration is now considered an essential component for ideal heart and brain health. Life's Essential 8 cardiovascular health score replaces...
Diabetes linked to substantial risk of left-sided valvular stenotic lesions Dr. Hiral patel27 Jun 2022 11:00 AM ISTSweden: A nationwide registry-based analysis reported that patients with type 1 and 2 diabetes are at higher risk for left-sided valvular stenotic...
Environmental exposures predict increased risk of death from cardiovascular disease Dr. Nandita Mohan25 Jun 2022 10:00 AM ISTA recent study quantifies that cardiovascular risk posed by exposure to specific environmental factors. for example, that air pollution heightens the...
Tirzepatide Slows CKD Progression among diabetes patients with Increased CV risk Dr. Kamal Kant Kohli7 Jun 2022 9:15 AM ISTTirzepatide can slow progression of chronic kidney disease in type 2 diabetes according to an analysis of SURPASS-4 data presented at ADA 2022. In...
Aspirin may prevent major CV events in patients with CKD Jacinthlyn Sylvia4 Jun 2022 12:15 PM ISTCanada: In a recent study done by Johannes F.E. Mann, it was seen that aspirin alone or in conjunction with a polypill may significantly reduce...
New Study Shows Cardiovascular Implications of Sleep Apnea Among Hispanics Dr. Kamal Kant Kohli31 May 2022 7:30 PM ISTResearchers found three different subtypes of hypertension, diabetes and cardiovascular risk among the participants of the Hispanic Community Health...
Aprocitentan found efficacious in patients with resistant hypertension in Phase 3 study Dr. Kamal Kant Kohli26 May 2022 7:45 PM ISTAprocitentan is an investigational, oral, dual endothelin receptor antagonist designed to potently inhibit the binding of endothelin-1 (ET-1) to ETA...
Thyroid hormone treatment connected to cardiovascular mortality Dr. Nandita Mohan19 May 2022 10:15 AM ISTIn a population-based cohort study of 705 307 adults who received thyroid hormone treatment, 10.8% died of cardiovascular causes. Both exogenous...
Cholesterol lowering drugs for high heart risk patients must be added Dr. Nandita Mohan16 May 2022 11:00 AM ISTA panel of international experts and patients in The BMJ said that additional cholesterol- lowering drugs should be offered to patients with high...
Reduction of CV events by PCSK9 inhibitors and ezetimibe: Clinical practice guideline Dr. Kamal Kant Kohli13 May 2022 9:30 AM ISTAdditional cholesterol lowering drugs should be offered to patients with high levels of 'bad' (LDL) cholesterol (70 mg/dl or higher) who are also at...
SGLT2 Inhibitors Reduce Hyperkalemia in High-Risk T2DM Patients MD Bureau3 May 2022 10:00 AM ISTHyperkalemia can occur in people with type 2 diabetes, especially in those with chronic kidney disease (CKD), and is clinically important because it...
